Showing results (341-350 of 437) with videos related to
Sort By:
Pageof 44
Cell Reports|March 31, 2015
An in vivo chemical genetic screen identifies phosphodiesterase 4 as a pharmacological target for hedgehog signaling inhibitionCharles H Williams, Jonathan E Hempel, Jijun Hao, et al.The Journal of Urology|May 1, 2023
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)Ashesh B Jani, Gregory C Ravizzini, Benjamin A Gartrell, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 1, 1997
Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and unc-38 encode functional nicotinic acetylcholine receptor subunitsJ T Fleming, M D Squire, T M Barnes, et al.AIDS (London, England)|October 16, 2001
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)S H Eshleman, M Mracna, L A Guay, et al.Diabetic Medicine : a Journal of the British Diabetic Association|March 13, 2015
The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark studyC S Hansen, T M Jensen, J S Jensen, et al.SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance|December 15, 2012
Perceptions of door-to-door HIV counselling and testing in BotswanaKaren Kroeger, Allan W Taylor, Heather M Marlow, et al.Investigational New Drugs|February 1, 1990
Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group studyS A Taylor, T Fleming, D D Von Hoff, et al.Scientific Reports|February 12, 2019
Automated microfluidic cell culture of stem cell derived dopaminergic neuronsKhalid I W Kane, Edinson Lucumi Moreno, Siham Hachi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2011
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancersXiao-Cheng Wu, Mary Jo Lund, Gretchen G Kimmick, et al.Cancer Epidemiology|November 26, 2015
Influence of patient, physician, and hospital characteristics on the receipt of guideline-concordant care for inflammatory breast cancerRyan A Denu, John M Hampton, Adam Currey, et al.Pageof 44